Prima Biomed Announces Japanese Patent Grants for IMP321 in Cancer
May 01, 2016 at 20:02 PM EDT
Prima BioMed Ltd (NASDAQ: PBMD) announces the granting of patent number 5908210 entitled "Use of Recombinant LAG-3 or the Derivatives ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.